These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30367791)

  • 1. Clinical relevance in present day hormonal contraception.
    Regidor PA
    Horm Mol Biol Clin Investig; 2018 Oct; 37(1):. PubMed ID: 30367791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical relevance of progestogens in hormonal contraception: Present status and future developments.
    Regidor PA
    Oncotarget; 2018 Oct; 9(77):34628-34638. PubMed ID: 30349654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New knowledge in the physiology of hormonal contraceptives.
    Lobo RA; Stanczyk FZ
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1499-507. PubMed ID: 8178898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting hormonal contraceptives for women.
    Garza-Flores J; Hall PE; Perez-Palacios G
    J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptive agents.
    Shearman RP
    Med J Aust; 1986 Feb; 144(4):201-5. PubMed ID: 3945219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contraception for women with diabetes: an update.
    Skouby SO; Mølsted-Pedersen L; Petersen KR
    Baillieres Clin Obstet Gynaecol; 1991 Jun; 5(2):493-503. PubMed ID: 1954724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why do inadvertent pregnancies occur in oral contraceptive users? Effectiveness of oral contraceptive regimens and interfering factors.
    Fraser IS; Jansen RP
    Contraception; 1983 Jun; 27(6):531-51. PubMed ID: 6413129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternate delivery systems for contraceptive progestogens.
    Ginsburg KA; Moghissi KS
    Fertil Steril; 1988 May; 49(5 Suppl 2):16S-30S. PubMed ID: 3282932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined oral contraceptives: acceptability and effective use.
    Kubba A; Guillebaud J
    Br Med Bull; 1993 Jan; 49(1):140-57. PubMed ID: 8324604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Historical survey of modern reversible contraceptive methods].
    Mbabajende V
    Imbonezamuryango; 1986 Apr; (5):14-7. PubMed ID: 12268230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New hormonal methods of contraception.
    Newton JR
    Baillieres Clin Obstet Gynaecol; 1996 Apr; 10(1):87-101. PubMed ID: 8736724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Information on advances in sciences and technology. Advances in contraceptive technology].
    Andrade AT
    Bol Cent Biol Reprod; 1993; 12(1):51-2. PubMed ID: 12345521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phasic approach to oral contraceptives.
    Hale RW
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1052-8. PubMed ID: 3118718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG; Steffens D; Schramm G
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The progestogen-only mini-pill.
    Graham S; Fraser IS
    Contraception; 1982 Oct; 26(4):373-88. PubMed ID: 6759029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile of contraceptive progestins.
    Benagiano G; Primiero FM; Farris M
    Eur J Contracept Reprod Health Care; 2004 Sep; 9(3):182-93. PubMed ID: 15697108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception.
    Russowsky M; Sartoretto JN
    Contraception; 1982 Jul; 26(1):41-9. PubMed ID: 7128133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.